|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/563 | |||
| C12N 15/00 | |||
| A61K 39/395 | |||
| C12P 21/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1417232 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02744320.9 |
| Europos patento paraiškos padavimo data | 2002-06-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-05-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2002/018748 |
| Data | 2002-06-13 |
| (87) | Numeris | WO 2002/100348 |
| Data | 2002-12-19 |
| (30) | Numeris | Data | Šalis |
| 298172 | 2001-06-13 | US |
| (72) |
VAN DE WINKEL, Jan, NL
VAN DIJK, Marcus A., NL
GERRITSEN, Arnout F., NL
HALK, Edward, US
|
| (73) |
Genmab A/S,
Bredgade 34 E, 1260 Copenhagen K,
DK
|
| (54) | HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) |
| HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) |